APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern
Abstract
This study assessed apolipoprotein E (APOE) ε4 carrier status effects on Alzheimer's disease imaging and cerebrospinal fluid (CSF) biomarkers in cognitively normal older adults with significant memory concerns (SMC).
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- May 07, 2015
- Source ID
- 10.1016/j.jalz.2015.03.003
Entities
People
- Andrew J. Saykin
- Clifford Jack
- John Q. Trojanowski
- Kwangsik Nho
- Laurel A. Beckett
- Leslie M. Shaw
- Michael W. Weiner
- Paul S. Aisen
- Robert A. Koeppe
- Ronald C. Petersen
- Shannon L. Risacher
- Shen Li
- Sungeun Kim
- Tatiana Foroud
- The Alzheimer's Disease Neuroimaging Initiative (adni)
- William J. Jagust
Organizations
- Alzheimer's Association
- Alzheimer's Disease Neuroimaging Initiative
- Dana Foundation
- Indiana University
- Mayo Clinic
- National Institute of Biomedical Imaging and Bioengineering
- National Institute on Aging
- National Institutes of Health
- United States Department of Defense
- United States Department of Veterans Affairs
- United States National Library of Medicine
- University of California, Berkeley
- University of California, Davis
- University of California, San Diego
- University of California, San Francisco
- University of Michigan
- University of Pennsylvania